Calls Now Open
2024 ADDF-Harrington + 2025 Harrington Scholar-Innovator Programs
April 16, 2024
Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2024 class of Harrington Scholar-Innovators. The scholar awards will support breakthrough new treatments for heart disease, autoimmune disorders, cancer, infectious disease, inflammation, and rare diseases using small molecule...
Continue ReadingMarch 15, 2016
CLEVELAND – The third annual Harrington Prize for Innovation in Medicine has been awarded to Jeffrey M. Friedman, MD, PhD, of The Rockefeller University, New York City, for his discovery of leptin and the leptin-mediated pathway that controls feeding behavior.The Harrington Prize for Innovation in Medicine, established in... Continue Reading
February 29, 2016
Formed by BioMotiv and Rutgers UniversityCLEVELAND AND NEW BRUNSWICK— FEBRUARY 29, 2016— BioMotiv, a drug development accelerator associated with The Harrington Project, and Rutgers, the State University of New Jersey, are announcing the formation of a new biotechnology startup, Z53 Therapeutics. Z53 Therapeutics aims to... Continue Reading
February 11, 2016
Dr. Jonathan Stamler, director of The Harrington Discovery Institute at University Hospitals in Cleveland, has earned a reputation as a “genius.”“Some people are geniuses,” his fatherâinâlaw Norman Wain said. “Geniuses have a capacity to work.”“He has this sort of infectious personality to want to drive... Continue Reading
January 13, 2016
Cleveland, Ohio – The Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio has announced the 2016 recipients of Harrington Scholar-Innovator Awards. The awards support breakthrough work of physician-scientists whose discovery research shows promise of advancing the standard of care.The Harrington... Continue Reading
January 08, 2016
Cleveland– January 8, 2016 – Dual Therapeutics, LLC (“Dual Therapeutics”) today announced a strategic collaboration with Bristol-Myers Squibb (NYSE: BMY) to advance small molecule compounds for the treatment of cancer and other diseases. Dual Therapeutics’ small-molecule modulators simultaneously block multiple cancer... Continue Reading
May 01, 2015
- 2015 Harrington Scholar-Innovator Continue Reading
May 01, 2015
- 2015 Harrington Scholar-Innovator Continue Reading
May 01, 2015
- 2015 Oxford-Harrington Scholar Continue Reading
May 01, 2015
- 2015 ADDF-Harrington Scholar Continue Reading
January 01, 2015
Momentum: Moving Medicine Forward Continue Reading